MaaT Pharma
ENXTPA:MAAT
5,68
€-0,28 (-4,70%)
5,68
€-0,28 (-4,70%)
End-of-day quote: 04/09/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€-2,21
Earnings Per Share
€0,28
Revenue Per Share
49,81%
Gross Margin %
€0,11 B
Market Cap
€0,01 B
Long-Term Debt
Earnings Per Share
€-2,21
Revenue Per Share
€0,28
Gross Margin %
49,81%
Market Cap
€0,11 B
Long-Term Debt
€0,01 B

Financials

Year Year 2024 2023 2020
EPS Earnings Per Share €-2,21 €-1,70 €-25,70
Earnings Earnings €-25,64M €-0,00M €-0,00M
RPS Revenue Per Share €0,28 N/A N/A
Revenue Revenue €3,22M €0,00M €0,00M
OCF Operating Cash Flow €-22,04M €0,00M €0,00M
FCF Free Cash Flow €-22,79M €0,00M €0,00M
OM Operating Margin 0,00% 0,00% 0,00%
GM % Gross Margin % 49,81% 60,59% 0,00%
FCFS Free Cash Flow Per Share €-1,74 €-1,74 €-5,97
LT Debt Long-Term Debt €8,11M N/A N/A
Sha. Stocks 11,6M 11,6M 0M
×